BRCA1 and cancer: Recent analysis of exome DNA resequencing data from treatment naïve OS has suggested that a significant fraction of OS might exhibit a pattern of chromosomal aberrations, specifically chromosomal loss of heterozygosity (LOH) effects, that are somewhat reminiscent of mutational patterns seen in tumours from cancer patients with germ-line BRCA1 or BRCA2 gene mutations5.